Amgen pays $290M to exit osteoporosis drug deal
Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S.
Ceres to plow $23M raise into sorghum tests
Thousand Oaks-based energy crop firm Ceres has raised $23 million that it hopes will help it to break even as it continues testing its seeds in Brazil.
Heritage Oaks names new CFO
Lonny Robinson has been named chief financial officer at Paso Robles-based Heritage Oaks Bancorp. Robinson, previously with Banc of California, will join Heritage Oaks as CFO and executive vice president on March 19.
Deckers’ global push takes toll on stock price
Deckers warned investors to expect a loss of 16 cents per share — compared to the 10-cent-per-share profit expected by Wall Street analysts — in the first quarter despite projected revenue growth. The company said that the reason was its aggressive build-out of its own branded retail stores around the world.
